Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.50    -28.50 (-3.25%)
Bid:
852.50
Ask:
854.50
Spread: 2.00 (0.235%)
Market Cap: £978.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Year-end Trading Update

15 Apr 2024 07:00

RNS Number : 5224K
Kainos Group plc
15 April 2024
 

15 April 2024

 

Kainos Group plc

("Kainos" or the "Company")

 

Year-end Trading Update

 

Kainos Group plc (KNOS), a UK-headquartered IT provider with expertise across three divisions - Digital Services, Workday Services, and Workday Products, today issues a trading update for the year ended 31 March 2024.

 

The Board expects to deliver solid growth in revenues and strong growth in adjusted PBT for the year. This will result in revenues being slightly below and adjusted PBT being in line with consensus forecasts*.

 

Overall, our business has continued to prove resilient in the current economic climate, particularly in our Workday Products and Services segments. We believe that given the macro-economic environment, we have maintained the appropriate balance between growth, international expansion, investment for the future and profitability.

 

· In Digital Services, our public sector team delivered another solid revenue performance and a strong sales performance and healthcare revenues continued to recover following the pandemic-related peak. This performance has been offset by weakness in demand within our commercial clients.

 

· As a leading partner in the Workday consulting sector, our Workday Services division continues to generate good growth as we engage in valuable relationships with international clients in all significant European and North American markets.

 

· Our Workday Products division recorded a very strong performance, both in our established products,Smart Test (for automated testing), Smart Audit (for compliance monitoring) and Smart Shield (for data masking), and in Employee Document Management, which launched in September 2023 and has been our most successful product launch to date.

 

We remain confident in our strategy. Our core markets have proven to be resilient and offer substantial further growth opportunities and we are well positioned within these markets, both locally and, increasingly, internationally. 

 

Our confidence is reinforced by our long-term customer relationships, and the calibre of our people, who continue to excel in delivering high-impact solutions for our customers. As always, we are grateful for the ongoing trust of our customers and the efforts of our colleagues across the world.

 

In the near-term, an increased backlog, a robust pipeline and a strong balance sheet provide excellent visibility of the strength of our performance in the current financial year.

 

Our results for the full year ended 31 March 2024 will be announced on 20 May 2024.

 

* Note: Company compiled range is based on known sell side analyst estimates. The ranges are: Revenue £395.4m - £404.1m and Adjusted PBT £71.7m - £78.6m. The respective consensus figures are £400.7m and £76.3m.

 

ENDS

 

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Russell Sloan, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +4420 7597 5970

Patrick Robb / Ben Griffiths

 

FTI Consulting LLP +44 20 3727 1000

Dwight Burden / Kwaku Aning

 

About Kainos Group plc

Kainos Group plc is a UK-headquartered IT provider with expertise across three divisions: Digital Services, Workday Services, and Workday Products.

 

· Digital Services develops and supports custom digital service platforms for public sector, commercial, and healthcare customers. Our solutions transform the delivery of these services, ensuring they are secure, accessible, and cost-effective, and provide better outcomes for users.

 

· Workday Services specialises in the deployment of Workday, Inc.'s Finance, HR and Planning products to leading organisations across Europe and North America. We are one of Workday's most respected partners, experienced in complex deployment and trusted by our customers to launch, test, expand, and support their Workday systems.

 

· Workday Products develops products that complement Workday. Our established Smart product suite, including Smart Test (for automated testing), Smart Audit (for compliance monitoring), and Smart Shield (for data masking), and the recently launched Employee Document Management, are used by more than 450 customers globally.

 

Our people are central to our success. We employ more than 2,900 people in 22 countries across Europe and the Americas.

 

We are listed on the London Stock Exchange (LSE: KNOS) and you can discover more about us at www.kainos.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAPLAFADLEFA
Date   Source Headline
4th Jun 202611:31 amRNSDirector / PDMR shareholdings
1st Jun 202610:27 amRNSTotal Voting Rights
18th May 20267:00 amRNSFull Year Results
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 202611:06 amRNSTotal Voting Rights
28th Apr 20261:38 pmRNSBoard and Board Committee Changes
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSYear-end Trading Update
14th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:22 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20265:10 pmRNSDirector Declaration
24th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20263:16 pmRNSNotification of Major Holdings
17th Mar 202611:28 amRNSDirector/PDMR shareholdings
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20264:58 pmRNSNotification of Transactions of Director/PDMR
12th Mar 20262:13 pmRNSHolding(s) in Company
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:30 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20269:43 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.